ZENAS BIOPHARMA
Live / Allowed — Notice of allowance issued (as of 22 Jul 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Jun 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98625409
- Mark type
- Design + words
- Filed
- 28 Jun 2024
- Published for opposition
- 27 May 2025
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the nature of auto-immune and immune-based therapies for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune and immune-based diseases
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; scientific and medical research services; pharmaceutical development services, namely, development of auto-immune and immune-based therapies
Owner
- Zenas BioPharma, Inc., Waltham, MA, US
- Zenas BioPharma, Inc., Waltham, MA, US
Prior registrations
Prosecution history
- 18 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 22 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 May 2025 — PUBLISHED FOR OPPOSITION
- 21 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Apr 2025 — EXAMINER'S AMENDMENT ENTERED
- 28 Apr 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 28 Apr 2025 — EXAMINERS AMENDMENT E-MAILED
- 28 Apr 2025 — EXAMINERS AMENDMENT -WRITTEN
- 22 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED